Anzeige
Mehr »
Login
Donnerstag, 14.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Investment in die Zukunft: Absoluter Geheimtipp - diese Aktie beschleunigt deine Renditechancen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
431 Leser
Artikel bewerten:
(2)

New America Energy Corp.: Third Bench Executes a Binding Letter of Intent with Residential Cabinetry Manufacturer

Finanznachrichten News

NEW YORK, NY / ACCESSWIRE / October 4, 2022 / New America Energy Corp. (OTC PINK:NECA), and its operating subsidiary, Third Bench Holdings, LLC ("Third Bench" or the "Company"), are pleased to report that the Company has entered into a Binding Letter of Intent to acquire Rasmussen Custom Cabinetry, LLC ("Rasmussen"). Rasmussen manufactures, distributes, and installs residential cabinets north of Salt Lake City, Utah.

New America Energy Corp., Tuesday, October 4, 2022, Press release picture

The Company is excited to add Rasmussen to its mix of companies. The Utah market is very strong, and Rasmussen is ideally positioned to continue to ramp up sales in Utah.

In addition, Rasmussen has the capacity to manufacture residential cabinets to be shipped to the Company's Davis Kitchens locations in Albuquerque, New Mexico and Tucson, Arizona, as well as the Company's Las Cruces Cabinets location in Las Cruces, New Mexico.

This acquisition will be immediately accretive to the Company's earnings. David Fair, the Company's CEO stated, "We are very excited about the vertical integration opportunities for all of our operations through the acquisition of Rasmussen. Having our own captive residential cabinetry brand really differentiates us from our competition. We can also have better control over lead times, design approaches, colors, and styles."

Rasmussen is on a run rate to have revenue of over $10 million in 2022. Combined with the current Third Bench operations, Rasmussen should be in a position to almost double that output by manufacturing cabinets for Third Bench's subsidiaries.

In addition, Rasmussen's Founder Colton Rasmussen, and Rasmussen's CFO Joshua Riedesel will continue to manage and operate Rasmussen under Third Bench.

Mr. Fair continued, "We have been extremely impressed by Colton and Josh. Their accomplishments in building Rasmussen into what it is today are tremendous. We are very happy to have them as an integral part of our management team. Their energy and commitment to excellence is outstanding and inspiring." David goes on to say "There will be tremendous synergistic value with this acquisition by selling their cabinets at our residential operations throughout the Southwest."

About Third Bench Holdings, LLC

Third Bench, subsidiary of New America Energy Corp., operates five subsidiary companies operating as architectural millwork and dealers in the cabinetry, kitchen and bath areas. Third Bench, through its subsidiary companies, offers products in these categories: residential cabinets and countertops and commercial millwork throughout the Western U.S. for customers from California to Texas. Third Bench also provides installation services as a part of its vertical offering. Third Bench employs over 130 people and had revenue of about $24 million in 2021. These projections have been provided by management and do not include the additional acquisitions that are currently under review.

Third Bench Holdings, LLC
175 S. Main Street #1410
Salt Lake City, UT 84111
https://thirdbench.com/

NECA Contact:
Investor Relations
info@thirdbench.com
https:/twitter.com/necaholdings

Safe Harbor

This release may contain certain forward-looking statements regarding our prospective performance and strategies within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations of our company, are generally identified by use of words "anticipate," "believe," "estimate," "expect," "intend," "plan," "project," "seek," "strive," "try," or future or conditional verbs such as "could," "may," "should," "will," "would," or similar expressions. Our ability to predict results or the actual effects of our plans or strategies is inherently uncertain. Accordingly, actual results may differ materially from anticipated results. Some of the factors that could cause our actual results to differ from our expectations or beliefs include, without limitation, the risks discussed from time to time in our filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Except as required by applicable

SOURCE: New America Energy Corp.



View source version on accesswire.com:
https://www.accesswire.com/718704/Third-Bench-Executes-a-Binding-Letter-of-Intent-with-Residential-Cabinetry-Manufacturer

© 2022 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.